Inappropriate ICD Shocks Linked to Brugada Syndrome
By HospiMedica International staff writers Posted on 23 Aug 2016 |
Researchers at Academic Medical Center (AMC, Amsterdam, The Netherlands) conducted a study in 88 consecutive BrS patients (mean age 49 years; 47% men) who were screened at AMC and CardioCenter Ticino (Lugano, Switzerland) to see if they were suitable for an sICD. All patients underwent QRS/T-wave morphology analysis before and after ajmaline infusion. At baseline, 76% of the patients had a normal ECG, 19% had a type 3BrS-ECG, and 5% had a type 2 BrS-ECG.
The researchers found that morphology analysis failed in 24% of patients upon development of a type 1 ECG pattern during ajmaline testing, all due to more pronounced T-waves; all the patients had true morphology analysis at baseline. They concluded that as sICD arrhythmia discrimination is based on a comparison between a template acquired after implantation and a spontaneously occurring arrhythmia, it is susceptible to QRS-/T-wave over-sensing, and is a leading cause of inappropriate shocks by an sICD. The study was published on August 9, 2016, in the Journal of the American College of Cardiology (JACC).
“Sensing might be particularly difficult in Brugada syndrome patients because of the dynamic nature of the ECG morphology. These patients are accordingly at risk for inappropriate shocks,” concluded lead author Louise R.A. Olde Nordkamp, MD, PhD, of AMC, and colleagues. “We therefore recommend that in the presence of a type-1 Brugada Syndrome ECG after subcutaneous ICD implantation, for example during fever or during an additional ajmaline test, all three sensing vectors should be evaluated, and the best suitable sensing vector should be programmed.”
BrS is a genetic disease characterized by abnormal ECG findings and an increased risk of sudden cardiac death (SCD) due to ventricular fibrillation. Over time and during fever, the ECG of BrS patients may change from a type 3 or 2 Brugada ECG to type 1 Brugada ECG, which is characterized by prominent ST-T segment changes. Approximately 20% of BrS cases have been shown to be associated with mutations in a gene that encodes for a sodium ion channel in myocyte cell membranes.
Related Links:
Academic Medical Center
CardioCenter Ticino
The researchers found that morphology analysis failed in 24% of patients upon development of a type 1 ECG pattern during ajmaline testing, all due to more pronounced T-waves; all the patients had true morphology analysis at baseline. They concluded that as sICD arrhythmia discrimination is based on a comparison between a template acquired after implantation and a spontaneously occurring arrhythmia, it is susceptible to QRS-/T-wave over-sensing, and is a leading cause of inappropriate shocks by an sICD. The study was published on August 9, 2016, in the Journal of the American College of Cardiology (JACC).
“Sensing might be particularly difficult in Brugada syndrome patients because of the dynamic nature of the ECG morphology. These patients are accordingly at risk for inappropriate shocks,” concluded lead author Louise R.A. Olde Nordkamp, MD, PhD, of AMC, and colleagues. “We therefore recommend that in the presence of a type-1 Brugada Syndrome ECG after subcutaneous ICD implantation, for example during fever or during an additional ajmaline test, all three sensing vectors should be evaluated, and the best suitable sensing vector should be programmed.”
BrS is a genetic disease characterized by abnormal ECG findings and an increased risk of sudden cardiac death (SCD) due to ventricular fibrillation. Over time and during fever, the ECG of BrS patients may change from a type 3 or 2 Brugada ECG to type 1 Brugada ECG, which is characterized by prominent ST-T segment changes. Approximately 20% of BrS cases have been shown to be associated with mutations in a gene that encodes for a sodium ion channel in myocyte cell membranes.
Related Links:
Academic Medical Center
CardioCenter Ticino
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration